| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/31/2006 | CN1778324A Effective part of nightshadeleaf ironweed for antiscolic medicines and its preparation and use |
| 05/31/2006 | CN1778321A Chinese Medicine for treating acne |
| 05/31/2006 | CN1778313A Medicine for preventing skin superficial fungalinfection and female genital infection |
| 05/31/2006 | CN1778294A Butin and its derivative and its use in preparation of pigmental metabolic disease medicine |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/31/2006 | CN1257741C Badger fat hair-growth promoting ointment and its preparation method |
| 05/31/2006 | CN1257738C Medicinal composition for treating burn and its preparation process |
| 05/31/2006 | CN1257733C Skin and mueosa tissue disinfectant and its processing method |
| 05/31/2006 | CN1257731C Pollen and medicinal composition for cosmetics and its preparation |
| 05/31/2006 | CN1257718C Chinese traditional medicine composition and its preparation and quality control method thereof |
| 05/30/2006 | US7053230 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053120 Use of carboxy compounds such as 2(4-acetoxyphenyl)2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053050 administering erythropoietin receptor antagonist or mimetics thereof |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052716 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives |
| 05/30/2006 | US7052684 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/26/2006 | WO2006055418A1 Cyclosporine for treating mucin deficiency |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054119A1 Topical formulations for use in the treatment or prevention of dermatological conditions |
| 05/26/2006 | WO2006053791A2 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/26/2006 | WO2006053708A1 Improved detergent composition |
| 05/26/2006 | WO2006053699A1 Pharmaceutical composition comprising a macrolide t-cell immunomodulator and anti-photoaging agent |
| 05/26/2006 | WO2006053390A1 A method of modulating b cell functioning |
| 05/26/2006 | WO2006053379A1 Improved nutraceutical composition |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | CA2629529A1 Plant extracts and dermatological uses thereof |
| 05/26/2006 | CA2587658A1 Antibiotic compounds, compositions and medical uses |
| 05/26/2006 | CA2587545A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/26/2006 | CA2587407A1 A method of modulating b cell functioning |
| 05/26/2006 | CA2581503A1 Pharmaceutical composition comprising a macrolide t-cell immunomodulator and anti-photoaging agent |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111356 External preparation for allergic diseases |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111282 for treatment of blood coaggulation disorders; trauma |
| 05/25/2006 | US20060110475 Composition containing in combination at least one bourd oil and at least one borage oil, use thereof as medicine, as dermatological or dermato-cosmetic agent |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110448 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
| 05/25/2006 | US20060110413 Novel Molecules dervied from noraporphine |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110343 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 05/24/2006 | EP1659131A2 Polypeptides and nucleic acids encoding the same |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659117A1 2-naphthylimino-1,3-thiazine derivative |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658856A1 Exendins for glucagon suppression |
| 05/24/2006 | EP1658855A2 Use of substance p for mobilization or proliferation of mesenchymal stem cells and for wound healing |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658088A1 Prebiotically active plant extracts |
| 05/24/2006 | EP1658064A2 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1465577A4 Methods for improving the aesthetic appearance of skin |
| 05/24/2006 | EP1453431A4 Method and apparatus for the stimulation of hair growth |
| 05/24/2006 | EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1322383B1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 05/24/2006 | EP1242102B1 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 05/24/2006 | EP1212410B1 Dna encoding the human serine protease eos |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | DE202006004435U1 Foot care product in the form of creams, foam-creams, ointments and balsam, useful for treating diabetic foot syndrome with or without wounds, comprises urea and oregano oil |
| 05/24/2006 | CN1777433A Topical formulation of ivermectin for the treatment of dermatological conditions |
| 05/24/2006 | CN1777410A Cosmetic for depigmentation |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775275A External-use lotion of Chinese medicine for treating skin disease and perineum disease |
| 05/24/2006 | CN1775247A Fleece-flower root and rhizoma rehmanniae preparation and new preparing method |
| 05/24/2006 | CN1775231A Chinese angelica ku-seng preparation and novel preparing method |
| 05/24/2006 | CN1775230A Enhanced Xihuang formulation and new preparing method |
| 05/24/2006 | CN1775227A Ointment medicine for treating bedsore |
| 05/24/2006 | CN1775224A Medical stone lotion for treating skin disease and its preparing method |
| 05/24/2006 | CN1775221A External medicine for treating wart, helosis and callosity |
| 05/24/2006 | CN1775212A Use of pirfenidone for treating psoriasis |
| 05/24/2006 | CN1775211A Method and composition for reducing to xicity related to leflunomide treatment |
| 05/24/2006 | CN1775088A Malt sugar |
| 05/24/2006 | CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 05/24/2006 | CN1256966C Traditional Chinese medicinal ointment for treaing burns and scald |
| 05/24/2006 | CN1256951C Use of sea dog soft capsule in preparing health products for dispelling chloasma |